• 1
    Rapaport SI. Coagulation problems in liver disease. Blood Coagul Fibrinolysis 2000; 11(Suppl. 1): S6974.
  • 2
    Lisman T, Leebeek FW, De Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37: 2807.
  • 3
    Roberts LR, Kamath PS. Pathophysiology and treatment of variceal hemorrhage. Mayo Clin Proc 1996; 71: 97383.
  • 4
    Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 38893.
  • 5
    Dillon JF, Simpson KJ, Hayes PC. Liver biopsy bleeding time: an unpredictable event. J Gastroenterol Hepatol 1994; 9: 26971.
  • 6
    McVay PA, Toy PT. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990; 94: 74753.
  • 7
    Caturelli E, Squillante MM, Andriulli A, Siena DA, Cellerino C, De Luca F, Marzano MA, Pompili M, Rapaccini GL. Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 1993; 13: 2703.
  • 8
    Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 1999; 81: 37881.
  • 9
    Boks AL, Brommer EJ, Schalm SW, Van Vliet HH. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 7986.
  • 10
    Porte RJ, Knot EA, Bontempo FA. Hemostasis in liver transplantation. Gastroenterology 1989; 97: 488501.
  • 11
    Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannucci PM. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 5538.
  • 12
    Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez AJ, Fabricius S, Erhardtsen E, De Franchis R. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004; 127: 112330.
  • 13
    Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121: 1319.
  • 14
    Bongers TN, Lisman T, Adelmeijer J, Janssen HLA, De Maat MPM, De Groot PG, Leebeek FWG. Highly elevated levels of von Willebrand factor in patients with liver cirrhosis support platelet adhesion despite its reduced functional capacity. J Thromb Haemost 2005; 3(Suppl. 1): 281 (Abstract).